ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma

Abstract

This study investigated the prognosis and immune infiltration of the ERBB family in cutaneous melanoma. Our results suggest that ERBB1/2/3 may serve as early prognostic markers and potential therapeutic targets in cutaneous melanoma.